Company / Return on Assets (ROA)
Edwards Lifesciences Return on Assets (ROA) History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
7.8%
FY2025
5-year range
7.8% / 32.0%
FY2021-FY2025
Trend
-75.5%
vs FY2024
Sector context
#30 of 159
Health Care
What the data says
Edwards Lifesciences's return on assets (roa) of 7.8% is higher than 81% of companies in the Health Care sector (FY2025). Return on Assets (ROA) has fluctuated over the past 5 years, ranging from 7.8% in FY2025 to 32.0% in FY2024.
Based on SEC 10-K filings.
7.8% in FY2025 with a 3-year CAGR of -10.5%. Top quartile in the Health Care sector.
Declined from 16.1% to 7.8% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -10.5pp
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
+454.4% above sector average
Key checks
Key Insights
- In FY2025, return on assets (roa) decreased 75.5% year-over-year.
- Currently 10.1pp above the Health Care sector average.
- Peak return on assets (roa) was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 3.16 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 7.8% | -75.5% |
| FY2024 | 32.0% | +99.3% |
| FY2023 | 16.1% | -12.5% |
| FY2022 | 18.4% | +3.8% |
| FY2021 | 17.7% | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026